EV Biologics Designs Process for Scalable Exosome Biopharmaceutical Manufacturing

Author's Avatar
Feb 22, 2021
Article's Main Image

NASHVILLE, TN / ACCESSWIRE / February 22, 2021 / EV Biologics Corp, (OTC PINK:YECO), today announced that during its Q1 R&D meeting, the executive board reviewed and has approved a plan for cGMP process development and scalable biomanufacturing of exosome biopharmaceuticals.